"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country

The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 heal...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 55; no. 2; pp. 584 - 593
Main Authors Das, Kausik, Sarkar, Rajib, Ahmed, Sk. Mahiuddin, Mridha, Asit R., Mukherjee, Partha S., Das, Kshaunish, Dhali, Gopal K., Santra, Amal, Chowdhury, Abhijit
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.02.2012
Wiley
Wolters Kluwer Health, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free‐living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m2) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. Conclusion: LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. (Hepatology 2012)
AbstractList The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m2) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. Conclusion: LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. (Hepatology 2012)
The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in ), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m super(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 plus or minus 1.78 versus 5.51 plus or minus 1.59 and 6.60 plus or minus 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 plus or minus 5.49 versus 5.63 plus or minus 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. Conclusion: LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. (Hepatology 2012)
The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease.
The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups.UNLABELLEDThe liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups.LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease.CONCLUSIONLSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease.
Author Mukherjee, Partha S.
Das, Kausik
Das, Kshaunish
Santra, Amal
Chowdhury, Abhijit
Ahmed, Sk. Mahiuddin
Mridha, Asit R.
Dhali, Gopal K.
Sarkar, Rajib
Author_xml – sequence: 1
  givenname: Kausik
  surname: Das
  fullname: Das, Kausik
  organization: Department of Department of Hepatology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 2
  givenname: Rajib
  surname: Sarkar
  fullname: Sarkar, Rajib
  organization: Department of Gastroenterology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 3
  givenname: Sk. Mahiuddin
  surname: Ahmed
  fullname: Ahmed, Sk. Mahiuddin
  organization: Department of Department of Hepatology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 4
  givenname: Asit R.
  surname: Mridha
  fullname: Mridha, Asit R.
  organization: Department of Pathology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 5
  givenname: Partha S.
  surname: Mukherjee
  fullname: Mukherjee, Partha S.
  organization: Liver Foundation, West Bengal, India
– sequence: 6
  givenname: Kshaunish
  surname: Das
  fullname: Das, Kshaunish
  organization: Department of Gastroenterology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 7
  givenname: Gopal K.
  surname: Dhali
  fullname: Dhali, Gopal K.
  organization: Department of Gastroenterology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 8
  givenname: Amal
  surname: Santra
  fullname: Santra, Amal
  organization: Department of the Center for Liver Research, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
– sequence: 9
  givenname: Abhijit
  surname: Chowdhury
  fullname: Chowdhury, Abhijit
  email: achowdhury2002@yahoo.co.in
  organization: Department of Department of Hepatology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25589053$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21952989$$D View this record in MEDLINE/PubMed
BookMark eNp90s1u1DAQB_AIFdEPOPACyCpCtIe0jmM7MbeqKlukpRQB4mg5zqTr4tjBThb2KXhlTHcXpAo4WRr9_mONPfvZjvMOsuxpgU8KjMnpAoYTQrmgD7K9gpEqL0uGd7I9TCqci6IUu9l-jLcYY0FJ_SjbJYVgRNRiL_txeOVDr-whsmYJAcXRdJ2DGFEPKk4B0NH8w9tjtFR2gohUKizMzSJJ41DjxwWyoBxSrkW-gQip3JqlaSdl4yt0hgY_TFaNxru8URHadMHUrlAXfI8UamEJ1g_G3SDtJzeG1ePsYZei8GRzHmSfXl98PL_M5-9mb87P5rlmhaA5rTmpQdEaSNtwAMqw0AwEb7HmNdWspR0QSklDKCGa4KZkFS8qzHUKcVUeZC_XfYfgv6bJRtmbqMFa5cBPUYqiFmVJBUny6L-yqCrOec0YS_T5PXrrp-DSHEklQxISST3bqKnpoZVDML0KK7n9lARebICKWtkuKKdN_OMYqwVmZXKna6eDjzFAJ7UZ7956DMpYWWD5az1kWg95tx4pcXwvsW36N7vp_s1YWP0bysuL620iXydMHOH774QKXySvyorJz1czWc_I_Lou3st5-RMK1ta-
CODEN HPTLD9
CitedBy_id crossref_primary_10_14309_ajg_0000000000000357
crossref_primary_10_1016_j_jaim_2020_12_015
crossref_primary_10_1111_tri_12073
crossref_primary_10_1093_ofid_ofw121
crossref_primary_10_3748_wjg_v28_i18_2021
crossref_primary_10_1371_journal_pone_0085067
crossref_primary_10_1016_j_jhep_2021_04_044
crossref_primary_10_1097_MEG_0000000000001092
crossref_primary_10_5005_jp_journals_10013_1121
crossref_primary_10_2478_rjim_2018_0034
crossref_primary_10_1093_carcin_bgx145
crossref_primary_10_1002_jmri_24084
crossref_primary_10_1007_s10620_014_3293_1
crossref_primary_10_1016_j_ultrasmedbio_2015_03_007
crossref_primary_10_22141_2308_2097_56_4_2022_519
crossref_primary_10_1007_s00330_012_2748_z
crossref_primary_10_1016_j_dld_2016_07_020
crossref_primary_10_1080_15476286_2020_1768353
crossref_primary_10_1002_hep_27981
crossref_primary_10_1111_liv_12136
crossref_primary_10_4103_ijem_IJEM_31_18
crossref_primary_10_1007_s00261_020_02717_x
crossref_primary_10_5005_jp_journals_10018_1067
crossref_primary_10_1371_journal_pone_0147879
crossref_primary_10_1186_s40001_023_01205_4
crossref_primary_10_5009_gnl16078
crossref_primary_10_1016_S1665_2681_19_31391_2
crossref_primary_10_1002_hep_25712
crossref_primary_10_1016_j_ultrasmedbio_2014_05_008
crossref_primary_10_1016_j_gene_2012_07_077
crossref_primary_10_1002_hep_25714
crossref_primary_10_1111_jgh_12318
crossref_primary_10_3389_fimmu_2022_975027
crossref_primary_10_1111_jgh_13762
crossref_primary_10_3390_nu14142808
crossref_primary_10_1111_liv_12623
crossref_primary_10_1007_s10620_021_07049_4
crossref_primary_10_1097_RUQ_0000000000000522
crossref_primary_10_1016_j_jceh_2022_10_008
crossref_primary_10_1002_hep_28843
crossref_primary_10_15406_ghoa_2016_05_00145
crossref_primary_10_1016_j_clinre_2019_06_007
crossref_primary_10_1016_j_jhep_2015_04_006
crossref_primary_10_1093_gastro_goae024
crossref_primary_10_1093_gastro_got007
crossref_primary_10_1186_s40001_023_01543_3
crossref_primary_10_1002_jgh3_12878
crossref_primary_10_1016_j_cgh_2022_01_015
crossref_primary_10_1002_jcu_23888
crossref_primary_10_1016_j_cgh_2018_08_069
crossref_primary_10_1016_j_jhepr_2020_100067
crossref_primary_10_1371_journal_pone_0203486
crossref_primary_10_1371_journal_pone_0110012
crossref_primary_10_1016_S1665_2681_19_31341_9
crossref_primary_10_1155_2015_624596
crossref_primary_10_4254_wjh_v5_i5_264
crossref_primary_10_1136_gutjnl_2018_317334
crossref_primary_10_1016_j_cgh_2012_09_025
crossref_primary_10_1055_s_0044_1782163
crossref_primary_10_1111_1751_2980_12868
crossref_primary_10_1016_j_ultrasmedbio_2012_11_015
crossref_primary_10_1016_S2468_1253_17_30034_1
crossref_primary_10_1371_journal_pone_0149843
crossref_primary_10_1093_ofid_ofw156
crossref_primary_10_1111_jgh_14311
crossref_primary_10_5582_ddt_2019_01009
crossref_primary_10_1002_ijc_33111
crossref_primary_10_1038_ajg_2012_331
crossref_primary_10_7863_ultra_14_10001
Cites_doi 10.1111/j.1440-1746.2007.05002.x
10.1172/JCI116769
10.1093/ije/dyl244
10.1002/hep.22056
10.1152/ajpgi.00032.2007
10.1016/S0140-6736(08)60383-9
10.1210/jc.2008-1595
10.1136/gut.2010.221382
10.1016/S0016-5085(19)35563-5
10.1002/hep.21665
10.1016/j.jhep.2009.02.010
10.1002/hep.23425
10.1002/hep.22577
10.1016/j.jhep.2010.06.022
10.1002/hep.23567
10.1016/S0168-8278(99)80297-9
10.1053/gast.2002.36061
10.1053/j.gastro.2011.02.058
10.1002/hep.21306
10.1016/j.jhep.2009.11.018
10.1002/hep.22759
10.1002/hep.510240201
10.1186/1471-230X-10-40
10.1002/hep.21347
10.1016/j.jhep.2010.07.033
10.1016/j.jhep.2008.02.008
10.3851/IMP1570
10.1002/hep.20701
10.1007/BF00280883
10.1115/1.4002369
10.1016/j.cgh.2008.03.005
10.1053/j.gastro.2008.02.075
10.1136/gut.2007.126417
10.1053/jhep.2003.50157
10.1016/S0140-6736(05)67402-8
10.1177/016173461003200405
10.1371/journal.pone.0003857
10.1620/tjem.139.43
10.1111/j.1440-1746.2005.04070.x
10.1016/j.jhep.2007.11.020
ContentType Journal Article
Copyright Copyright © 2011 American Association for the Study of Liver Diseases
2015 INIST-CNRS
Copyright © 2011 American Association for the Study of Liver Diseases.
Copyright_xml – notice: Copyright © 2011 American Association for the Study of Liver Diseases
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 American Association for the Study of Liver Diseases.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
H94
K9.
7X8
DOI 10.1002/hep.24694
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3350
EndPage 593
ExternalDocumentID 3958150871
21952989
25589053
10_1002_hep_24694
HEP24694
ark_67375_WNG_8G2LP81Q_L
Genre article
Journal Article
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
186
1B1
1CY
1L6
1OB
1OC
1ZS
1~5
24P
31~
33P
3O-
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AAONW
AAQFI
AAQQT
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABMAC
ABOCM
ABPVW
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADOZA
ADXAS
ADZMN
ADZOD
AECAP
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD8
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
M65
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RGB
RIG
RIWAO
RJQFR
ROL
RPZ
RWI
RX1
RYL
SEW
SSZ
SUPJJ
TEORI
UB1
V2E
V9Y
W2D
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AANHP
ABWVN
ACLDA
ACRPL
ACYXJ
ADNMO
AAYXX
ABJNI
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c5194-48628ea48e2db6ee4509c5e96d0c684c5d4fe2442b2422c20b35761706ca486a3
IEDL.DBID DR2
ISSN 0270-9139
1527-3350
IngestDate Fri Jul 11 10:28:22 EDT 2025
Fri Jul 11 16:14:57 EDT 2025
Fri Jul 25 09:50:45 EDT 2025
Thu Apr 03 07:02:01 EDT 2025
Mon Jul 21 09:12:48 EDT 2025
Thu Apr 24 22:55:47 EDT 2025
Tue Jul 01 03:33:29 EDT 2025
Wed Jan 22 17:01:43 EST 2025
Wed Oct 30 09:52:18 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Human
Obesity
Liver
Nutrition disorder
Gastroenterology
Developing countries
Nutritional status
Language English
License CC BY 4.0
Copyright © 2011 American Association for the Study of Liver Diseases.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5194-48628ea48e2db6ee4509c5e96d0c684c5d4fe2442b2422c20b35761706ca486a3
Notes ArticleID:HEP24694
ark:/67375/WNG-8G2LP81Q-L
Potential conflict of interest: Nothing to report.
istex:4A158DB1B346C3467BB5E22289EE80F6A5C533B4
fax: +913322235435
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 21952989
PQID 1766825559
PQPubID 996352
PageCount 10
ParticipantIDs proquest_miscellaneous_918933492
proquest_miscellaneous_1776668555
proquest_journals_1766825559
pubmed_primary_21952989
pascalfrancis_primary_25589053
crossref_citationtrail_10_1002_hep_24694
crossref_primary_10_1002_hep_24694
wiley_primary_10_1002_hep_24694_HEP24694
istex_primary_ark_67375_WNG_8G2LP81Q_L
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2012
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 02
  year: 2012
  text: February 2012
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken, NJ
– name: United States
PublicationTitle Hepatology (Baltimore, Md.)
PublicationTitleAlternate Hepatology
PublicationYear 2012
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley
Wolters Kluwer Health, Inc
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley
– name: Wolters Kluwer Health, Inc
References Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis by transient elastography. J Hepatol 2008; 48: 835-847.
Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993; 92: 1795-1804.
Bedossa P, Poynard T; The French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293.
Green R, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-1384.
Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis. HEPATOLOGY 2008; 48: 1718-1723.
Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. HEPATOLOGY 2003; 37: 802-809.
Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851.
Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526.
Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008; 6: 828-831.
Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613.
Farrell GC, Chitturi S, Lau GKK, Sollano JD, for the Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777.
Roan E. The effect of Glisson's capsule on the superficial elasticity measurements of the liver. J Biomech Eng 2010; 132: 104-105.
Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 2010; 10: 40.
Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449-1457.
Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. HEPATOLOGY 2010; 51: 1593-1602.
Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-984.
Poynard T, Ngo Y, Munteanu M, Thabut D, Massard J, Moussalli J, et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Antivir Ther 2010; 15: 617-631.
Orescanin M, Qayyum MA, Toohey KS, Insana MF. Dispersion and shear modulus measurements of porcine liver. Ultrason Imaging 2010; 32: 255-266.
Yoneda M, Fujita K, Inamori M, Nakajima A, Tamano M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1331.
Food and Agriculture Organization of the United Nations. The double burden of malnutrition: case studies from six developing countries. FAO Food Nutr Pap 2006; 84: 1-334.
WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595.
Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659.
Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver Dis 2009; 18: 57-60.
Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? HEPATOLOGY 2006; 44: 513-514.
Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. HEPATOLOGY 2010; 51: 828-835.
Ghany MG, Strader DB, Thomas DL, Seef LB. AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
Vergniol J, Foucher J, Terrebonne E, Bernard PH, Bail BL, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979.
Kleiner DE, Brunt EM, Natta MV, Behling C, Contos MJ, Cummings OW, et al. for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 1313-1321.
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
Quigley MA. Shifting burden of disease-epidemiological transition in India. Int J Epidemiol 2006; 35: 1530-1531.
Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974.
Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008; 3: e3857.
Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1147-G1154.
Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210.
Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958; 35: 190-199.
Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard when everything else fails. J Hepatol 2009; 50: 1267-1268.
Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-1384.
Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol 2005; 20: 1712-1720.
Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297.
Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-S30.
1983; 139
2004; 363
1985; 28
2010; 32
2010; 10
2010; 15
2006; 35
2011; 60
1958; 35
2005; 41
2003; 37
2005; 20
2011; 54
2003; 38
2008; 6
2008; 3
2008; 93
2007; 56
2009; 49
2006; 84
2007; 293
2009; 50
2006; 44
2005; 366
1993; 92
2002; 123
2010; 132
2008; 47
2008; 48
1999; 31
1992; 24
2008; 134
2011; 140
1996; 24
2007; 22
2007; 45
2010; 52
2010; 51
2008; 371
2009; 18
Lok (R23-27-20241201) 2007; 45
Roulot (R10-27-20241201) 2008; 48
Castera (R7-27-20241201) 2010; 51
Rockey (R47-27-20241201) 1993; 92
Farrell (R21-27-20241201) 2007; 22
Vergniol (R2-27-20241201) 2011; 140
Kleiner (R26-27-20241201) 2005; 41
Millonig (R36-27-20241201) 2008; 48
Alvarez (R24-27-20241201) 1999; 31
Misra (R14-27-20241201) 2008; 93
Poynard (R8-27-20241201) 2008; 3
Bedossa (R4-27-20241201) 1996; 24
Roulot (R6-27-20241201) 2011; 60
Orescanin (R32-27-20241201) 2010; 32
(R30-27-20241201) 2006; 84
Schuppan (R20-27-20241201) 2008; 371
(R13-27-20241201) 2004; 363
Rockey (R46-27-20241201) 1992; 24
Sirli (R31-27-20241201) 2009; 18
Vizzutti (R34-27-20241201) 2007; 45
Chowdhury (R15-27-20241201) 2003; 37
Ghany (R22-27-20241201) 2009; 49
Millonig (R35-27-20241201) 2010; 52
Bedossa (R44-27-20241201) 2003; 38
Georges (R9-27-20241201) 2007; 293
Chowdhury (R16-27-20241201) 2005; 20
Das (R12-27-20241201) 2010; 51
Sagir (R37-27-20241201) 2008; 47
Corpechot (R11-27-20241201) 2006; 44
Williams (R28-27-20241201) 2006; 44
Quigley (R29-27-20241201) 2006; 35
Yoneda (R38-27-20241201) 2007; 56
Matthews (R19-27-20241201) 1985; 28
Gaia (R39-27-20241201) 2011; 54
FriedrichRust (R5-27-20241201) 2008; 134
Castera (R1-27-20241201) 2008; 48
Menghini (R25-27-20241201) 1958; 35
Poynard (R41-27-20241201) 2010; 10
Poynard (R42-27-20241201) 2010; 15
Roan (R33-27-20241201) 2010; 132
Kumar (R3-27-20241201) 2008; 134
Yajima (R17-27-20241201) 1983; 139
Jacqueminet (R40-27-20241201) 2008; 6
Tsochatzis (R43-27-20241201) 2011; 54
Alberti (R18-27-20241201) 2005; 366
Green (R27-27-20241201) 2002; 123
Poynard (R45-27-20241201) 2009; 50
22419516 - Hepatology. 2012 Sep;56(3):1183-4; author reply 1184-5
References_xml – reference: Ghany MG, Strader DB, Thomas DL, Seef LB. AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
– reference: Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
– reference: Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. HEPATOLOGY 2003; 37: 802-809.
– reference: Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? HEPATOLOGY 2006; 44: 513-514.
– reference: Green R, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-1384.
– reference: Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis. HEPATOLOGY 2008; 48: 1718-1723.
– reference: Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613.
– reference: Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
– reference: Food and Agriculture Organization of the United Nations. The double burden of malnutrition: case studies from six developing countries. FAO Food Nutr Pap 2006; 84: 1-334.
– reference: Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595.
– reference: Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974.
– reference: Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297.
– reference: Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526.
– reference: Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851.
– reference: Bedossa P, Poynard T; The French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293.
– reference: Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard when everything else fails. J Hepatol 2009; 50: 1267-1268.
– reference: Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659.
– reference: Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008; 3: e3857.
– reference: Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958; 35: 190-199.
– reference: WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
– reference: Orescanin M, Qayyum MA, Toohey KS, Insana MF. Dispersion and shear modulus measurements of porcine liver. Ultrason Imaging 2010; 32: 255-266.
– reference: Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
– reference: Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
– reference: Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-984.
– reference: Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. HEPATOLOGY 2010; 51: 1593-1602.
– reference: Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993; 92: 1795-1804.
– reference: Vergniol J, Foucher J, Terrebonne E, Bernard PH, Bail BL, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979.
– reference: Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-S30.
– reference: Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449-1457.
– reference: Roan E. The effect of Glisson's capsule on the superficial elasticity measurements of the liver. J Biomech Eng 2010; 132: 104-105.
– reference: Yoneda M, Fujita K, Inamori M, Nakajima A, Tamano M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1331.
– reference: Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. HEPATOLOGY 2010; 51: 828-835.
– reference: Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis by transient elastography. J Hepatol 2008; 48: 835-847.
– reference: Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-1384.
– reference: Quigley MA. Shifting burden of disease-epidemiological transition in India. Int J Epidemiol 2006; 35: 1530-1531.
– reference: Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
– reference: Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210.
– reference: Farrell GC, Chitturi S, Lau GKK, Sollano JD, for the Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777.
– reference: Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203.
– reference: Poynard T, Ngo Y, Munteanu M, Thabut D, Massard J, Moussalli J, et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Antivir Ther 2010; 15: 617-631.
– reference: Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1147-G1154.
– reference: Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver Dis 2009; 18: 57-60.
– reference: Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
– reference: Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 2010; 10: 40.
– reference: Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol 2005; 20: 1712-1720.
– reference: Kleiner DE, Brunt EM, Natta MV, Behling C, Contos MJ, Cummings OW, et al. for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 1313-1321.
– reference: Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008; 6: 828-831.
– volume: 366
  start-page: 1059
  year: 2005
  end-page: 1062
  article-title: The metabolic syndrome—a new worldwide definition
  publication-title: Lancet
– volume: 44
  start-page: 513
  year: 2006
  end-page: 514
  article-title: Gender and liver: is the liver stiffness weaker in weaker sex?
  publication-title: HEPATOLOGY
– volume: 49
  start-page: 1335
  year: 2009
  end-page: 1374
  article-title: AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update
  publication-title: Hepatology
– volume: 45
  start-page: 507
  year: 2007
  end-page: 539
  article-title: Chronic hepatitis B
  publication-title: Hepatology
– volume: 371
  start-page: 838
  year: 2008
  end-page: 851
  article-title: Liver cirrhosis
  publication-title: Lancet
– volume: 51
  start-page: 1593
  year: 2010
  end-page: 1602
  article-title: Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease
  publication-title: HEPATOLOGY
– volume: 123
  start-page: 1367
  year: 2002
  end-page: 1384
  article-title: AGA technical review on the evaluation of liver chemistry tests
  publication-title: Gastroenterology
– volume: 44
  start-page: 521
  year: 2006
  end-page: 526
  article-title: Global challenges in liver disease
  publication-title: Hepatology
– volume: 84
  start-page: 1
  year: 2006
  end-page: 334
  article-title: The double burden of malnutrition: case studies from six developing countries
  publication-title: FAO Food Nutr Pap
– volume: 51
  start-page: 828
  year: 2010
  end-page: 835
  article-title: Pitfalls of liver stiffness measurement: a 5‐year prospective study of 13,369 examinations
  publication-title: HEPATOLOGY
– volume: 93
  start-page: S9
  year: 2008
  end-page: S30
  article-title: Obesity and the metabolic syndrome in developing countries
  publication-title: J Clin Endocrinol Metab
– volume: 24
  start-page: 193
  year: 1992
  end-page: 203
  article-title: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture
  publication-title: J Submicrosc Cytol Pathol
– volume: 48
  start-page: 835
  year: 2008
  end-page: 847
  article-title: Non‐invasive evaluation of liver fibrosis by transient elastography
  publication-title: J Hepatol
– volume: 35
  start-page: 190
  year: 1958
  end-page: 199
  article-title: One‐second needle biopsy of the liver
  publication-title: Gastroenterology
– volume: 45
  start-page: 1290
  year: 2007
  end-page: 1297
  article-title: Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis
  publication-title: Hepatology
– volume: 47
  start-page: 592
  year: 2008
  end-page: 595
  article-title: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
  publication-title: Hepatology
– volume: 54
  start-page: 650
  year: 2011
  end-page: 659
  article-title: Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta‐analysis of diagnostic accuracy
  publication-title: J Hepatol
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  article-title: for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: HEPATOLOGY
– volume: 48
  start-page: 1718
  year: 2008
  end-page: 1723
  article-title: Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis
  publication-title: HEPATOLOGY
– volume: 37
  start-page: 802
  year: 2003
  end-page: 809
  article-title: Hepatitis C virus infection in the general population: a community‐based study in West Bengal, India
  publication-title: HEPATOLOGY
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  article-title: Homeostasis model assessment: insulin resistance and B‐cell function from fasting glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 54
  start-page: 64
  year: 2011
  end-page: 71
  article-title: Reliability of transient elastography for the detection of fibrosis in non‐alcoholic fatty liver disease and chronic viral hepatitis
  publication-title: J Hepatol
– volume: 38
  start-page: 1449
  year: 2003
  end-page: 1457
  article-title: Sampling variability of liver fibrosis in chronic hepatitis C
  publication-title: HEPATOLOGY
– volume: 35
  start-page: 1530
  year: 2006
  end-page: 1531
  article-title: Shifting burden of disease—epidemiological transition in India
  publication-title: Int J Epidemiol
– volume: 31
  start-page: 929
  year: 1999
  end-page: 938
  article-title: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis
  publication-title: J Hepatol
– volume: 50
  start-page: 1267
  year: 2009
  end-page: 1268
  article-title: Liver biopsy: the best standard when everything else fails
  publication-title: J Hepatol
– volume: 32
  start-page: 255
  year: 2010
  end-page: 266
  article-title: Dispersion and shear modulus measurements of porcine liver
  publication-title: Ultrason Imaging
– volume: 139
  start-page: 43
  year: 1983
  end-page: 50
  article-title: Ultrasonographical diagnosis of fatty liver: significance of the liver‐kidney contrast
  publication-title: Tohoku J Exp Med
– volume: 52
  start-page: 206
  year: 2010
  end-page: 210
  article-title: Liver stiffness is directly influenced by central venous pressure
  publication-title: J Hepatol
– volume: 140
  start-page: 1970
  year: 2011
  end-page: 1979
  article-title: Noninvasive tests for fibrosis and liver stiffness predict 5‐year outcomes of patients with chronic hepatitis C
  publication-title: Gastroenterology
– volume: 56
  start-page: 1330
  year: 2007
  end-page: 1331
  article-title: Transient elastography in patients with non‐alcoholic fatty liver disease (NAFLD)
  publication-title: Gut
– volume: 6
  start-page: 828
  year: 2008
  end-page: 831
  article-title: Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes
  publication-title: Clin Gastroenterol Hepatol
– volume: 132
  start-page: 104
  year: 2010
  end-page: 105
  article-title: The effect of Glisson's capsule on the superficial elasticity measurements of the liver
  publication-title: J Biomech Eng
– volume: 60
  start-page: 977
  year: 2011
  end-page: 984
  article-title: Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community‐based population aged over 45 years
  publication-title: Gut
– volume: 48
  start-page: 606
  year: 2008
  end-page: 613
  article-title: Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome
  publication-title: J Hepatol
– volume: 22
  start-page: 775
  year: 2007
  end-page: 777
  article-title: Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia‐Pacific region: executive summary
  publication-title: J Gastroenterol Hepatol
– volume: 15
  start-page: 617
  year: 2010
  end-page: 631
  article-title: Biomarkers of liver injury for hepatitis clinical trials: a meta‐analysis of longitudinal studies
  publication-title: Antivir Ther
– volume: 18
  start-page: 57
  year: 2009
  end-page: 60
  article-title: Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness?
  publication-title: J Gastrointest Liver Dis
– volume: 24
  start-page: 289
  year: 1996
  end-page: 293
  article-title: An algorithm for grading activity in chronic hepatitis C
  publication-title: HEPATOLOGY
– volume: 92
  start-page: 1795
  year: 1993
  end-page: 1804
  article-title: Activation‐dependent contractility of rat hepatic lipocytes in culture and in vivo
  publication-title: J Clin Invest
– volume: 134
  start-page: 1376
  year: 2008
  end-page: 1384
  article-title: Virologic and histologic features of chronic hepatitis B virus‐infected asymptomatic patients with persistently normal ALT
  publication-title: Gastroenterology
– volume: 134
  start-page: 960
  year: 2008
  end-page: 974
  article-title: Performance of transient elastography for the staging of liver fibrosis: a meta‐analysis
  publication-title: Gastroenterology
– volume: 10
  start-page: 40
  year: 2010
  article-title: Prevalence of liver fibrosis and risk factors in a general population using non‐invasive biomarkers (FibroTest)
  publication-title: BMC Gastroenterol
– volume: 363
  start-page: 157
  year: 2004
  end-page: 163
  article-title: Appropriate body‐mass index for Asian populations and its implications for policy and intervention strategies
  publication-title: Lancet
– volume: 293
  start-page: G1147
  year: 2007
  end-page: G1154
  article-title: Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 20
  start-page: 1712
  year: 2005
  end-page: 1720
  article-title: Community‐based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen‐negative infection and associated viral variants
  publication-title: J Gastroenterol Hepatol
– volume: 3
  start-page: e3857
  year: 2008
  article-title: Concordance in a world without a gold standard: a new non‐invasive methodology for improving accuracy of fibrosis markers
  publication-title: PLoS One
– volume: 22
  start-page: 775777
  year: 2007
  ident: R21-27-20241201
  article-title: Guidelines for the assessment and management of nonalcoholic fatty liver disease in the AsiaPacific region: executive summary.
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2007.05002.x
– volume: 92
  start-page: 17951804
  year: 1993
  ident: R47-27-20241201
  article-title: Activationdependent contractility of rat hepatic lipocytes in culture and in vivo.
  publication-title: J Clin Invest
  doi: 10.1172/JCI116769
– volume: 84
  start-page: 1334
  year: 2006
  ident: R30-27-20241201
  article-title: The double burden of malnutrition: case studies from six developing countries.
  publication-title: FAO Food Nutr Pap
– volume: 35
  start-page: 15301531
  year: 2006
  ident: R29-27-20241201
  article-title: Shifting burden of diseaseepidemiological transition in India.
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyl244
– volume: 363
  start-page: 157163
  year: 2004
  ident: R13-27-20241201
  article-title: Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies.
  publication-title: Lancet
– volume: 47
  start-page: 592595
  year: 2008
  ident: R37-27-20241201
  article-title: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage.
  publication-title: Hepatology
  doi: 10.1002/hep.22056
– volume: 293
  start-page: G1147G1154
  year: 2007
  ident: R9-27-20241201
  article-title: Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis.
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00032.2007
– volume: 134
  start-page: 960974
  year: 2008
  ident: R5-27-20241201
  article-title: Performance of transient elastography for the staging of liver fibrosis: a metaanalysis.
  publication-title: Gastroenterology
– volume: 371
  start-page: 838851
  year: 2008
  ident: R20-27-20241201
  article-title: Liver cirrhosis.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60383-9
– volume: 93
  start-page: S9S30
  year: 2008
  ident: R14-27-20241201
  article-title: Obesity and the metabolic syndrome in developing countries.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-1595
– volume: 60
  start-page: 977984
  year: 2011
  ident: R6-27-20241201
  article-title: Transient elastography as a screening tool for liver fibrosis and cirrhosis in a communitybased population aged over 45 years.
  publication-title: Gut
  doi: 10.1136/gut.2010.221382
– volume: 35
  start-page: 190199
  year: 1958
  ident: R25-27-20241201
  article-title: Onesecond needle biopsy of the liver.
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(19)35563-5
– volume: 45
  start-page: 12901297
  year: 2007
  ident: R34-27-20241201
  article-title: Liver stiffness measurement predicts severe portal hypertension in patients with HCVrelated cirrhosis.
  publication-title: Hepatology
  doi: 10.1002/hep.21665
– volume: 18
  start-page: 5760
  year: 2009
  ident: R31-27-20241201
  article-title: Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness?
  publication-title: J Gastrointest Liver Dis
– volume: 50
  start-page: 12671268
  year: 2009
  ident: R45-27-20241201
  article-title: Liver biopsy: the best standard when everything else fails.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2009.02.010
– volume: 38
  start-page: 14491457
  year: 2003
  ident: R44-27-20241201
  article-title: Sampling variability of liver fibrosis in chronic hepatitis C.
  publication-title: Hepatology
– volume: 51
  start-page: 828835
  year: 2010
  ident: R7-27-20241201
  article-title: Pitfalls of liver stiffness measurement: a 5year prospective study of 13,369 examinations.
  publication-title: Hepatology
  doi: 10.1002/hep.23425
– volume: 48
  start-page: 17181723
  year: 2008
  ident: R36-27-20241201
  article-title: Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis.
  publication-title: Hepatology
  doi: 10.1002/hep.22577
– volume: 54
  start-page: 6471
  year: 2011
  ident: R39-27-20241201
  article-title: Reliability of transient elastography for the detection of fibrosis in nonalcoholic fatty liver disease and chronic viral hepatitis.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.06.022
– volume: 51
  start-page: 15931602
  year: 2010
  ident: R12-27-20241201
  article-title: Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.
  publication-title: Hepatology
  doi: 10.1002/hep.23567
– volume: 31
  start-page: 929938
  year: 1999
  ident: R24-27-20241201
  article-title: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis.
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(99)80297-9
– volume: 123
  start-page: 13671384
  year: 2002
  ident: R27-27-20241201
  article-title: AGA technical review on the evaluation of liver chemistry tests.
  publication-title: Gastroenterology
  doi: 10.1053/gast.2002.36061
– volume: 140
  start-page: 19701979
  year: 2011
  ident: R2-27-20241201
  article-title: Noninvasive tests for fibrosis and liver stiffness predict 5year outcomes of patients with chronic hepatitis C.
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.02.058
– volume: 44
  start-page: 513514
  year: 2006
  ident: R11-27-20241201
  article-title: Gender and liver: is the liver stiffness weaker in weaker sex?
  publication-title: Hepatology
  doi: 10.1002/hep.21306
– volume: 52
  start-page: 206210
  year: 2010
  ident: R35-27-20241201
  article-title: Liver stiffness is directly influenced by central venous pressure.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2009.11.018
– volume: 49
  start-page: 13351374
  year: 2009
  ident: R22-27-20241201
  article-title: AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update.
  publication-title: Hepatology
  doi: 10.1002/hep.22759
– volume: 24
  start-page: 289293
  year: 1996
  ident: R4-27-20241201
  article-title: An algorithm for grading activity in chronic hepatitis C.
  publication-title: Hepatology
  doi: 10.1002/hep.510240201
– volume: 10
  start-page: 40
  year: 2010
  ident: R41-27-20241201
  article-title: Prevalence of liver fibrosis and risk factors in a general population using noninvasive biomarkers (FibroTest).
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-10-40
– volume: 44
  start-page: 521526
  year: 2006
  ident: R28-27-20241201
  article-title: Global challenges in liver disease.
  publication-title: Hepatology
  doi: 10.1002/hep.21347
– volume: 54
  start-page: 650659
  year: 2011
  ident: R43-27-20241201
  article-title: Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a metaanalysis of diagnostic accuracy.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.07.033
– volume: 48
  start-page: 835847
  year: 2008
  ident: R1-27-20241201
  article-title: Noninvasive evaluation of liver fibrosis by transient elastography.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.02.008
– volume: 15
  start-page: 617631
  year: 2010
  ident: R42-27-20241201
  article-title: Biomarkers of liver injury for hepatitis clinical trials: a metaanalysis of longitudinal studies.
  publication-title: Antivir Ther
  doi: 10.3851/IMP1570
– volume: 41
  start-page: 13131321
  year: 2005
  ident: R26-27-20241201
  article-title: for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 28
  start-page: 412419
  year: 1985
  ident: R19-27-20241201
  article-title: Homeostasis model assessment: insulin resistance and Bcell function from fasting glucose and insulin concentrations in man.
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 132
  start-page: 104105
  year: 2010
  ident: R33-27-20241201
  article-title: The effect of Glissons capsule on the superficial elasticity measurements of the liver.
  publication-title: J Biomech Eng
  doi: 10.1115/1.4002369
– volume: 6
  start-page: 828831
  year: 2008
  ident: R40-27-20241201
  article-title: Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2008.03.005
– volume: 134
  start-page: 13761384
  year: 2008
  ident: R3-27-20241201
  article-title: Virologic and histologic features of chronic hepatitis B virusinfected asymptomatic patients with persistently normal ALT.
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.02.075
– volume: 56
  start-page: 13301331
  year: 2007
  ident: R38-27-20241201
  article-title: Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD).
  publication-title: Gut
  doi: 10.1136/gut.2007.126417
– volume: 24
  start-page: 193203
  year: 1992
  ident: R46-27-20241201
  article-title: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.
  publication-title: J Submicrosc Cytol Pathol
– volume: 37
  start-page: 802809
  year: 2003
  ident: R15-27-20241201
  article-title: Hepatitis C virus infection in the general population: a communitybased study in West Bengal, India.
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50157
– volume: 366
  start-page: 10591062
  year: 2005
  ident: R18-27-20241201
  article-title: The metabolic syndromea new worldwide definition.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67402-8
– volume: 32
  start-page: 255266
  year: 2010
  ident: R32-27-20241201
  article-title: Dispersion and shear modulus measurements of porcine liver.
  publication-title: Ultrason Imaging
  doi: 10.1177/016173461003200405
– volume: 3
  start-page: e3857
  year: 2008
  ident: R8-27-20241201
  article-title: Concordance in a world without a gold standard: a new noninvasive methodology for improving accuracy of fibrosis markers.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0003857
– volume: 139
  start-page: 4350
  year: 1983
  ident: R17-27-20241201
  article-title: Ultrasonographical diagnosis of fatty liver: significance of the liverkidney contrast.
  publication-title: Tohoku J Exp Med
  doi: 10.1620/tjem.139.43
– volume: 20
  start-page: 17121720
  year: 2005
  ident: R16-27-20241201
  article-title: Communitybased epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigennegative infection and associated viral variants.
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2005.04070.x
– volume: 48
  start-page: 606613
  year: 2008
  ident: R10-27-20241201
  article-title: Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2007.11.020
– volume: 45
  start-page: 507539
  year: 2007
  ident: R23-27-20241201
  article-title: Chronic hepatitis B.
  publication-title: Hepatology
– reference: 22419516 - Hepatology. 2012 Sep;56(3):1183-4; author reply 1184-5
SSID ssj0009428
Score 2.3307889
Snippet The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 584
SubjectTerms Adult
Biological and medical sciences
Case-Control Studies
Developing Countries
Elasticity
Elasticity Imaging Techniques
Female
Gastroenterology. Liver. Pancreas. Abdomen
Hepatology
Humans
India
Liver - physiopathology
Liver Cirrhosis - diagnosis
Liver Diseases - diagnosis
Liver Diseases - physiopathology
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Metabolic diseases
Middle Aged
Obesity
Obesity - physiopathology
Reference Values
ROC Curve
Title "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country
URI https://api.istex.fr/ark:/67375/WNG-8G2LP81Q-L/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.24694
https://www.ncbi.nlm.nih.gov/pubmed/21952989
https://www.proquest.com/docview/1766825559
https://www.proquest.com/docview/1776668555
https://www.proquest.com/docview/918933492
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRUJceEPdlmpACJWD02S9drxwqlDbCKVReVT0gGTtrtdq1eBEcSIBp_wELtzgz-WXMLN-REGthLhZ9ljWjmdnv9mZ_Yax552s2-E2C3yrpfQpE-jHYdr1cTnX2srIZNqxfQ6i3ql4exaerbHX9VmYkh-i2XCjmeH8NU1wpYu9JWnouR23OAZ3xAVKtVoEiN4vqaOkcH1VMepqU3ZZ1qxCbb7XvLmyFt0gtX6l2khVoHqysq_FVcBzFce6hejwDvtcD6GsP7lszaa6Zb7_xe74n2O8y25XABX2S4u6x9Zsfp_dPK5S8A_Yz8X814CA7nAx_w1DKusAdBNZRj4TvpRbjrDb_3D8EohJ3Bag8Ma5qyeBixw02gYMrcpB5SmMtC0sXDTHwopXsA_jpqvYYv6D1tkUHA0u0GEYULA86QWu18Xk20N2enjw8U3Pr3o7-AYxo_AFRlKxVSK2PNWRtQKBiwnRONK2iWJhwlRkFqEH14ghuOFtHWBkRFw_RMMeqeARW89Hud1gYMMwUzrNMhkaEbSlklIFWgQm5WkqjPLYbv2XE1MRn1P_jWFSUjbzBNWcODV77FkjOi7ZPq4SeuFMpZFQk0sqj-uGyafBURIf8f5J3HmX9D22s2JLzQsYxsUSvZ_HtmvjSirXUSTE2IlhO0Z6HnvaPMZJT5kcldvRjGRQKIpRyGNwjYzsIBQl7kmPPS7tdvn9jgyJeR8146zv-rEmvYMTd7H576Jb7BaiSl6Wtm-z9elkZp8gcpvqHTdF_wAIwEI3
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VVgIuvB-GUhaEUDk4dey140VcKmgbIIkKbUUvaLW7XqtVgxPlIQGn_AQu3ODP5Zcws04cBbUS4mbZY1k7np39Zmf2G4Bn9bxRD20e-VYL4VMm0E_jrOHjcq61FYnJtWP77CTNI_7uOD5egVfzszAlP0S14UYzw_lrmuC0Ib21YA09sf1aiNEdvwRr1NGbmPPffFyQRwnuOqti3BVQflnMeYWCcKt6dWk1WiPFfqXqSDVEBeVlZ4vzoOcyknVL0e51-DwfRFmBclYbj3TNfP-L3_F_R3kDrs0wKtsujeomrNjiFlxuz7Lwt-HndPKrQ1i3O538Zl2q7GDoKfKc3Cb7Uu46ss3WQfsFIzJxO2QKb5y4khJ2WjCN5sG6VhVMFRnraTu07LQ6GTZ8ybZZv2osNp38oKU2Y44Jl9F5GKbY4rAXc-0uBt_uwNHuzuHrpj9r7-AbhI3c5xhMpVbx1IaZTqzliF1MjPaRBSZJuYkznltEH6FGGBGaMNARBkdE90NM7ImK7sJq0SvsfWA2jnOlszwXseFRIJQQKtI8MlmYZdwoDzbnv1maGfc5teDoypK1OZSoZunU7MHTSrRfEn6cJ_Tc2UoloQZnVCHXiOWnzp5M98LWflr_IFsebCwZU_UCRnKpQAfowfrcuuTMewwlkXZi5I7BngdPqsc47ymZowrbG5MMCiUpCnnALpARdUSjRD_pwb3ScBffr4uYyPdRM878Lh6rbO7su4sH_y76GK40D9st2Xrbef8QriLIDMtK93VYHQ3G9hECuZHecPP1D_jURlM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJk288P0RGONACI2HdKnjpDE8TWxdga4asIk9IFl2bGvTSlr1QwKe-ifwwhv8c_1LODttqqJNQrxFyUWRL-fz73zn3xHyrG4bdWpsHBrFeegygWGW6EaIy7lShqe5VZ7ts5O2jtnbk-Rkhbyan4Up-SGqDTc3M7y_dhO8r-32gjT01PRrFIM7doWssTTirm_D7ocFdxRnvrEqhl2RSy_zOa1QRLerV5cWozWn16-uOFIOUT-2bGxxEfJcBrJ-JWpeJ5_nYygLUM5r45Gq5d__onf8z0HeINdmCBV2SpO6SVZMcYusH8xy8LfJz-nkV8ch3e508hu6rq4D0E9Y65wmfCn3HGGr_fHgBTgqcTMEiTdOfUEJnBWg0Diga2QBstDQU2Zo4Kw6FzZ8CTvQr9qKTSc_3EKrwfPggjsNAxIWR73AN7sYfLtDjpt7R69b4ay5Q5gjaGQhw1AqM5JlhmqVGsMQueQJWoeO8jRjeaKZNYg9qEIQQXMaqRhDI0f243jYUxnfJatFrzD3CZgksVJpa3mSszjiknMZKxbnmmrNchmQrflfFvmM-dw14OiKkrOZClSz8GoOyNNKtF_SfVwk9NybSiUhB-euPq6RiE-dfZHt0_ZhVn8v2gHZXLKl6gWM4zKO7i8gG3PjEjPfMRSOshPjdgz1AvKkeoyz3qVyZGF6YyeDQmmGQgGBS2R4HbGoI58MyL3Sbhffr_PEUe-jZrz1XT5W0do79BcP_l30MVk_3G2K9pvOu4fkKiJMWpa5b5DV0WBsHiGKG6lNP1v_APurRQI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%22Normal%22+liver+stiffness+measure+%28LSM%29+values+are+higher+in+both+lean+and+obese+individuals%3A+a+population-based+study+from+a+developing+country&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Das%2C+Kausik&rft.au=Sarkar%2C+Rajib&rft.au=Ahmed%2C+Sk+Mahiuddin&rft.au=Mridha%2C+Asit+R&rft.date=2012-02-01&rft.issn=1527-3350&rft.eissn=1527-3350&rft.volume=55&rft.issue=2&rft.spage=584&rft_id=info:doi/10.1002%2Fhep.24694&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon